1
|
Bando JK, Gilfillan S, Song C, McDonald K, Huang SCC, Newberry RD, Kobayashi Y, Allan DS, Carlyle JR, Cella M, Colonna M. Abstract B146: The tumor necrosis factor superfamily member RANKL suppresses effector cytokine production in group 3 innate lymphoid cells. Cancer Immunol Res 2019. [DOI: 10.1158/2326-6074.cricimteatiaacr18-b146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
While signals that activate group 3 innate lymphoid cells (ILC3s) have been described, the factors that negatively regulate these cells are less well understood. Here we found that the tumor necrosis factor (TNF) superfamily member receptor activator of nuclear factor κB ligand (RANKL) suppressed ILC3 activity in the intestine. Deletion of RANKL in ILC3s and T-cells increased C-C motif chemokine receptor 6 (CCR6)+ ILC3 abundance and enhanced production of interleukin-17A (IL-17A) and IL-22 in response to IL-23 and during infection with the enteric murine pathogen Citrobacter rodentium. Additionally, CCR6+ ILC3s produced higher amounts of the master transcriptional regulator RORγt at steady state in the absence of RANKL. RANKL-mediated suppression was independent of T-cells, and instead occurred via interactions between CCR6+ ILC3s that expressed both RANKL and its receptor, RANK. Thus, RANK-RANKL interactions between ILC3s regulate ILC3 abundance and activation, suggesting that cell clustering may control ILC3 activity.
Citation Format: Jennifer Kaoru Bando, Susan Gilfillan, Christina Song, Keely McDonald, Stanley C-C. Huang, Rodney D. Newberry, Yasuhiro Kobayashi, David S.J. Allan, James R. Carlyle, Marina Cella, Marco Colonna. The tumor necrosis factor superfamily member RANKL suppresses effector cytokine production in group 3 innate lymphoid cells [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr B146.
Collapse
Affiliation(s)
- Jennifer Kaoru Bando
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - Susan Gilfillan
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - Christina Song
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - Keely McDonald
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - Stanley C-C. Huang
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - Rodney D. Newberry
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - Yasuhiro Kobayashi
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - David S.J. Allan
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - James R. Carlyle
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - Marina Cella
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| | - Marco Colonna
- Washington University in St. Louis, Saint Louis, MO; Case Western Reserve University of Medicine, Cleveland, OH; Matsumoto Dental University, Shiojiri, Japan; National Institutes of Health, Bethesda, MD; University of Toronto, Toronto, Canada
| |
Collapse
|